MedPath

The effects of testosterone gel administration in ART

Phase 4
Conditions
infertility.
Female infertility associated with anovulation
Registration Number
IRCT201505197513N11
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
64
Inclusion Criteria

1-aged between 30 and 42 years
2-agreed to participate in the study
3- poor response to ovarian stimulation in IVF and ICSI methods previous (plasma estradiol level <1200 pg ml daily on HCG, the number of oocytes <5)
4- evidence of decreased ovarian reserve (which Drsvmyn day menstrual cycle, according to an abnormally low level of estradiol, inhibin B, and FSH defined)
5- no history of ovarian surgery, endometriosis, metabolic disorders and cancer Brest

Exclusion criteria:
1- not referring patients to determine the level of hormones in ovarian reserves
2- lack of testosterone gel completely or irregular use it to continue the development of allergies or severe medical complications of drug use is prohibited.
3-Pregnancy

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ovarian reserve hormones ( FSH-LH-Progestrone-E2). Timepoint: end of each cycle. Method of measurement: laboratory assessment.;Antral follicles numbers. Timepoint: end of each cycle. Method of measurement: sonography.;Antral follicles size. Timepoint: end of each cycle. Method of measurement: sonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath